Gossamer Bio (GOSS) Enterprise Value

Price: $0.84
Market Cap: $191.43M
Avg Volume: 1.52M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.883
52W Range: $0.499-1.55
Website: Gossamer Bio
Enterprise Value Summary (Quarterly)

According to Gossamer Bio's latest quarterly financial reports:

  • The enterprise value (EV) is 361.45M, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
  • The market capitalization is 204.65M, which is calculated by multiplying the current share price by the total number of outstanding shares.
  • The stock price is $0.9046, with 226.23M shares outstanding.
  • The company has 46.07M in cash and cash equivalents and 202.88M in total debt.

Enterprise Value (EV) Formula:

EV = Market Cap + Total Debt - Cash and Cash Equivalents

Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.

Enterprise Value

$361.45M

Market Cap

$204.65M

Total Debt

$202.88M

Cash and Equivalents

$46.07M

Historical Enterprise Value
$1.50B$1.50B$1.20B$1.20B$900.00M$900.00M$600.00M$600.00M$300.00M$300.00M$0.00$0.00Enterprise Value20182018201920192020202020212021202220222023202320242024
Gossamer Bio Historical Enterprise Values

The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-12-31.

Date Enterprise Value EV Change (%) Stock Price Number of Shares Market Cap Cash & Equivalents Total Debt
December 31, 2024 $361.45M -9.28% $0.9046 226.23M $204.65M $46.07M $202.88M
September 30, 2024 $398.43M 22.08% $0.9864 226.35M $223.27M $28.46M $203.63M
June 30, 2024 $326.37M -28.57% $0.9476 226.22M $214.37M $86.88M $198.88M
March 31, 2024 $456.87M 18.35% $1.27 225.74M $286.68M $38.86M $209.05M
December 31, 2023 $386.04M 31.37% $0.9125 225.41M $205.69M $32.11M $212.46M
September 30, 2023 $293.85M -0.96% $0.8328 192.88M $160.63M $82.61M $215.82M
June 30, 2023 $296.69M 7.36% $1.2 95.45M $114.54M $37.00M $219.16M
March 31, 2023 $276.35M -13.19% $1.26 94.55M $119.13M $65.24M $222.46M
December 31, 2022 $318.35M -72.74% $2.17 94.28M $204.59M $111.97M $225.74M
September 30, 2022 $1.17B 49.79% $11.98 91.18M $1.09B $153.48M $229.06M
June 30, 2022 $779.74M 3.61% $8.37 76.67M $641.71M $94.32M $232.34M
March 31, 2022 $752.57M -12.16% $8.68 75.89M $658.77M $138.91M $232.71M
December 31, 2021 $856.73M -6.23% $11.31 75.59M $854.90M $183.40M $185.24M
September 30, 2021 $913.66M 103.43% $12.57 75.00M $942.77M $213.47M $184.36M
June 30, 2021 $449.13M 4.41% $8.12 74.67M $606.34M $342.45M $185.24M
March 31, 2021 $430.17M 6.05% $9.25 74.09M $685.37M $439.66M $184.46M
December 31, 2020 $405.64M -34.32% $9.67 73.21M $707.96M $486.06M $183.73M
September 30, 2020 $617.63M 10.25% $12.41 72.25M $896.57M $461.96M $183.02M
June 30, 2020 $560.19M 0.77% $13 66.60M $865.80M $486.06M $180.45M
March 31, 2020 $555.90M -35.53% $10.15 61.89M $628.19M $111.35M $39.07M
December 31, 2019 $862.30M -7.22% $15.63 61.28M $957.84M $135.09M $39.55M
September 30, 2019 $929.39M -25.42% $16.79 60.76M $1.02B $130.71M $40.00M
June 30, 2019 $1.25B 110.17% $22.47 60.27M $1.35B $148.50M $40.45M
March 31, 2019 $592.90M 74.25% $20.68 36.32M $751.04M $170.85M $12.71M
December 31, 2018 $340.25M 11.78% $17.94 24.83M $445.47M $105.22M $-
September 30, 2018 $304.41M -26.35% $17.94 24.83M $445.47M $141.07M $-
June 30, 2018 $413.33M -7.28% $17.94 24.83M $445.47M $32.15M $-
March 31, 2018 $445.79M -1.20% $17.94 24.83M $445.47M $-315.00K $-
December 31, 2017 $451.20M 174.57% $17.94 24.83M $445.47M $315.00K $6.04M
September 30, 2017 $164.33M -0.01% $17.94 9.16M $164.33M $- $-
June 30, 2017 $164.35M 0.00% $17.94 9.16M $164.35M $- $-
March 31, 2017 $164.35M - $17.94 9.16M $164.35M $- $-

Related Metrics

Explore detailed financial metrics and analysis for GOSS.